Search Results - "Nisar, Muhammad K."

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease by Taylor, Peter C, Askari, Ayman, Choy, Ernest, Ehrenstein, Michael R, Else, Sara, Nisar, Muhammad K

“…Rheumatoid arthritis (RA) is a chronic inflammatory disease that is associated with joint pain and stiffness. Biologics represent some of the most effective…”
Get full text

Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach by Nisar, Muhammad K

Get full text

Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom by Nisar, Muhammad K., Rafiq, Aneesa, Östör, Andrew J. K.

“…Biologic therapies have resulted in a sea change in the management of inflammatory arthritis; however, a higher risk of opportunistic infection, particularly…”
Get full text

Does biologic survival depend on co-prescribed methotrexate dose in established rheumatoid arthritis? A real-world study by Mothojakan, Nadira B, Gore, Janki, Nisar, Muhammad K

“…Several seminal studies have suggested that a combination therapy of biologics with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs)…”
Get full text

Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis – A novel approach by Nisar, Muhammad K.

Get full text

Should All Patients Trial Subcutaneous Methotrexate Prior to Commencing Biologic Therapy? A Real World Study by Mirza, Anem, Nisar, Muhammad K

“…Methotrexate (MTX) is the bed rock of inflammatory arthritis management. However, intolerance is a limiting factor for drug optimisation and retention. There…”
Get full text

Early arthritis service is cost-effective, improves outcomes and reduces biologic use by Nisar, Muhammad K

Get full text

Crystallising the role of adrenocorticotrophic hormone in the management of acute gout: a review by Nisar, Muhammad K

“…Acute gout is traditionally treated with NSAIDs, corticosteroids, and colchicine. However, the presence of comorbid conditions and advancing age, often seen in…”
Get full text

Rheumatology nurse specialists and corticosteroids prescription—Is it safe? by Begum, Julie, Nisar, Muhammad K.

Get full text

Rheumatology nurse specialists and DMARD education – Is it fit for purpose? by Begum, Julie, Nisar, Muhammad K.

Get full text

Cupping (Hijama) Treatment: Benign or Sinister? by Nisar, Muhammad K

“…Cupping treatment is on the rise in the Western world as an alternative medicine modality.We present a hitherto unreported complication of bilateral subdural…”
Get full text

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review by Gout, Taras, Östör, Andrew J. K., Nisar, Muhammad K.

“…Tocilizumab, a monoclonal antibody targeting the IL-6 receptor, has recently been added to the therapeutic armamentarium against rheumatoid arthritis (RA)…”
Get full text

Non-infectious pulmonary toxicity of rituximab: a systematic review by HADJINICOLAOU, Andreas V, NISAR, Muhammad K, PARFREY, Helen, CHILVERS, Edwin R, ÖSTÖR, Andrew J. K

“…Rituximab (RTX), a B-cell depleting mAb, has been reported to cause pulmonary toxicity in many patients. As the use of this biologic is increasing, we have…”
Get full text

Adherence to biologic therapy – Does it vary with ethnicity? by Nisar, Muhammad K., Mirza, Waqas, Rafiq, Aneesa, Eisenhut, Michael

“…BackgroundPoor adherence to therapy remains a significant barrier to improving clinical outcomes in rheumatic diseases and carries a major financial burden. It…”
Get full text

Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world? by Mirza, Anem, Naing, Zeyar Win, Khonsari, Parisa, Khan, Haseeb, Abbas, Ali K, Nisar, Muhammad K

“…Aromatase inhibitor induced bone loss (AIBL) is a recognised adverse event with resultant increase in fracture risk. We aimed to determine the real-world…”
Get full text

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review by Hadjinicolaou, Andreas V., Nisar, Muhammad K., Bhagat, Shweta, Parfrey, Helen, Chilvers, Edwin R., Östör, Andrew J. K.

“…Objective. Lung disease is commonly encountered in rheumatological practice either as a manifestation of the underlying condition or as a consequence of using…”
Get full text

Interleukin-6 and cytochrome-P450, reason for concern? by Kim, Sooha, Östör, Andrew J. K., Nisar, Muhammad K.

“…Interleukin 6 (IL-6) plays a central role in the immunopathogenesis of rheumatoid arthritis (RA) and tocilizumab [TCZ] (an anti-IL-6 receptor antibody) has…”
Get full text

Giant Cell Hepatitis - A Rare Association with Connective Tissue Disease by Rauf, Maria, Sen, Sambit, Levene, Adam, Nisar, Muhammad K

“…A 68-year-old gentleman presented to hepatology department with asymptomatic year-long history of stably deranged liver function tests. His peak alkaline…”
Get full text

The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope by Hannah, Jennifer, Rodziewicz, Mia, Mehta, Puja, Heenan, Kerri-Marie, Ball, Elizabeth, Barratt, Shaney, Carty, Sara, Conway, Richard, Cotton, Caroline V, Cox, Sarah, Crawshaw, Anjali, Dawson, Julie, Desai, Sujal, Fahim, Ahmed, Fielding, Carol, Garton, Mark, George, Peter, Gunawardena, Harsha, Kelly, Clive, Khan, Fasihul, Koduri, Gouri, Morris, Helen, Naqvi, Marium, Perry, Elizabeth, Riddell, Claire, Sieiro Santos, Cristiana, Spencer, Lisa G, Chaudhuri, Nazia, Nisar, Muhammad K

“…Interstitial lung disease (ILD) is a significant complication of many systemic autoimmune rheumatic diseases (SARDs), although the clinical presentation,…”
Get full text

Chikungunya and bilateral sacroiliitis-is there a link? by Nisar, Muhammad K, Packianathan, Christabel

Get full text